J&J wins patent fight against Boston Scientific (CNN Money)

J&J wins patent fight against Boston Scientific (CNN Money)
Jury rules that J&J stent does not violate Boston Scientific patent. NEW YORK (Reuters) — A U.S. federal court has ruled that a drug-coated stent sold by Johnson and Johnson does not infringe a patent held by Boston Scientific Corp.